Grade 2 (Moderate) Ascites Not Responding to Anti-Mineralocorticoid Therapy

This protocol addresses the management of liver cirrhosis with a first episode of grade 2 (moderate) ascites when the initial diuretic approach has not produced a sufficient response — or when the patient develops hyperkalemia under that treatment.

Previous line — criteria for escalation

First-line management of this presentation combines moderate dietary sodium restriction with an anti-mineralocorticoid drug. Escalation to this protocol is triggered when that regimen fails to achieve a body weight reduction of at least 2 kg/week — or when hyperkalemia develops under anti-mineralocorticoid treatment.

Next step — partial overview

When anti-mineralocorticoid monotherapy does not reach the response threshold, furosemide is added in a stepwise fashion. The complete escalation sequence, specific criteria, and monitoring parameters are contained in the structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.jhep.2018.03.024

Patients with the first episode of grade 2 (moderate) ascites should receive an anti-mineralocorticoid drug alone, starting at 100 mg/day with stepwise increases every 72 h (in 100 mg steps) to a maximum of 400 mg/day if there is no response to lower doses (I;1).

In patients who do not respond to anti-mineralocorticoids, as defined by a body weight reduction of less than 2 kg/week, or in patients who develop hyperkalemia, furosemide should be added at an increasing stepwise dose from 40 mg/day to a maximum of 160 mg/day (in 40 mg steps) (I;1).

View source ↗